Because The World Can't Wait

"Ai Di Weixin has also recently successfully merged the innovative vaccine manufacturer, Sau Biotechnology. Founded in 2012, Si'ao Biotechnology focuses on the development and production of new genetically engineered vaccines and innovative test kits, and has a high-standard vaccine production facility base of nearly 20,000 square meters in Suzhou Industrial Park. With the completion of the merger, Adi Weixin will form a complete system covering vaccine research and development, production and quality management, and will build the base into a genetic engineering and nucleic acid vaccine production base with large-scale mass production capacity and international influence at the fastest speed. This will become the largest DNA vaccine production base in the country, with an annual production capacity of tens of millions to hundreds of millions of doses, and give priority to the production and supply of COVID-19 DNA vaccines. "